Today: 30 April 2026
Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results
20 January 2026
1 min read

Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results

London, January 20, 2026, 08:47 GMT — Regular session

  • Unilever (ULVR.L) slipped roughly 0.7% early in London, trading near 4,733p
  • Berenberg sticks with its Buy rating on Unilever, maintaining a 5,600p target price
  • Investors are eyeing the Feb. 12 results for clues on volume and margins following the ice cream demerger

Unilever (ULVR.L) shares edged down 0.7% to 4,732.5 pence in early London trade Tuesday. The stock hovered in a tight range, between 4,727p and 4,753p, with about 97,000 shares changing hands. Year to date, the shares are down roughly 2.6%.

European stocks slipped once more, pressured by trade tensions after U.S. President Donald Trump renewed tariff threats against several European nations. By 0803 GMT, the pan-European STOXX 600 had dropped 0.7%, Reuters noted.

Unilever had no clear new driver during the session. The shares moved as usual—anchored as a major defensive consumer stock that tends to follow broader market swings when risk appetite fades.

A broker note brought a company-specific angle. On Monday, Berenberg analyst Fulvio Cazzol reaffirmed a Buy rating, maintaining a target price of 5,600 pence and describing the stock as “attractive.” MarketScreener

Investors are eyeing the calendar closely. Unilever is set to release its fourth-quarter and full-year 2025 results on Feb. 12, with a scheduled appearance at the CAGNY Conference on Feb. 17, according to its investor site.

In a pre-close note dated Jan. 8, Unilever projected 2025 underlying sales growth—excluding currency and M&A effects—between 3% and 5%. The company expects second-half underlying operating margin to hit at least 19.5%. Fourth-quarter underlying volume growth should match or exceed the third quarter’s 1.7%. It also said tariff impacts on profitability were limited and already factored into margin forecasts.

February’s report will be the first to show a full year of figures excluding ice cream, now classified as discontinued following the split. Unilever announced in December that its ice cream division, renamed The Magnum Ice Cream Company, was spun off on Dec. 6. New shares began trading Dec. 8, with a share consolidation happening the next day.

Investors are now digging deeper into the remaining mix, searching for signs that volume can keep climbing even as price gains slow. They’re also looking for evidence that margins stay strong while the group invests in brands and drives productivity savings. Cash flow and any hints on capital returns will draw just as much scrutiny.

February’s numbers will be a clear turning point. Falling short on volumes, weaker margin guidance, or currency headwinds could swiftly change the outlook—even for a company primarily recognized for soap, deodorant, and pantry staples.

For now, macro factors will likely keep dominating the tape. Traders are focused on whether tariff threats turn into actual policy starting Feb. 1 and how that impacts overall risk sentiment. Unilever’s key upcoming events are its Feb. 12 earnings and the CAGNY presentation on Feb. 17.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Wesfarmers walks away from a $400m Priceline rescue — and now the Infinity pharmacies are up for grabs
Previous Story

Wesfarmers walks away from a $400m Priceline rescue — and now the Infinity pharmacies are up for grabs

Netflix earnings today: Traders price in a 7% swing as the Warner deal hangs over the stock
Next Story

Netflix earnings today: Traders price in a 7% swing as the Warner deal hangs over the stock

Go toTop